NCT01737450View on ClinicalTrials.gov

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2018

Study Completion Date

March 31, 2019

Conditions

Head and Neck NeoplasmsNeoplasm MetastasisRecurrent DiseaseProgressive Disease

Interventions

DRUG

BKM120

Trial Locations (9)

69003

Centre Hospitalier Lyon Sud, Pierre-Bénite

Unknown

Hopital St André, Bordeaux

Hôpital BEAUJON, Clichy

Centre Oscar Lambret, Lille

Centre Léon Bérard, Lyon

Centre Val d'Aurelle - Paul Lamarque, Montpellier

Centre Antoine LACASSAGNE, Nice

Institut Curie, Paris

Institut Gustave Roussy, Villejuif

All Listed Sponsors

collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Fondation ARC

OTHER

lead

Centre Leon Berard

OTHER

NCT01737450 - Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive | Biotech Hunter | Biotech Hunter